Corteva, Inc. · NYSE:CTVA

Corteva — Q4 2023 Earnings Presentation

36 slides from Corteva's earnings presentation, Feb 1, 2024

  1. Slide 1: 4Q 2023 Earnings Conference Call

    4Q 2023 Earnings Conference Call February 1, 2024

  2. Slide 2: Safe Harbor Regarding Forward-Looking Statements

    Safe Harbor Regarding Forward-Looking Statements Forward-Looking Statements This presentation contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, whi

  3. Slide 3: A Reminder About Non-GAAP Financial Measures

    A Reminder About Non-GAAP Financial Measures Regulation G (Non-GAAP Financial Measures) This presentation includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures may include organic sales, organic growth (including by segment and region), operatin

  4. Slide 4: CEO Messages: 2024 Guidance Reflects Continued Growth at Attractive Margin

    CEO Messages Strong  Record-setting demand for grain, oilseeds, meat, and biofuels in 2023 Global  On-farm product demand remains steady and overall healthy Demand  Global Crop Protection market remains imbalanced Solid  Delivered 116 basis points of Operating EBITDA margin(1) expansion for FY 2

  5. Slide 5: 2023 / 2024 Key Themes

    2023 / 2024 Key Themes Value Creation Strategy: Technology, Differentiated Products, and Ongoing Productivity 2023 Performance 2024 Expectations  Stand-out Seed performance  Continued Seed growth  CP destocking / industry imbalance  CP volume growth partially offset by price  Solid earnings gro

  6. Slide 6: 2023 Financial Performance

    2023 Financial Performance Metric 4Q 2023 FY 2023 2023 Highlights $3.7B $17.2B Strong market demand in Seed offset by CP channel Net Sales destocking and Brazil market dynamics 3% 1% $3.5B $17.0B Organic growth in North America(2) and EMEA(2) Organic Sales(1) offset by 4% headwind from product / Rus

  7. Slide 7: 2023 Sales Highlights

    2023 Sales Highlights Global Net Sales FY 2023 Sales by Segment Seed Crop Protection $17.46B $17.23B $9.47B $8.98B $8.48B Reported ~$400M of $7.75B 1% CP exits Organic(1) 3% FY 2022 FY 2023 FY 2022 FY 2023 FY 2022 FY 2023 Reported 5% Reported 9% Organic(1) 7% Organic(1) 12% • Seed Performance Reflec

  8. Slide 8: FY 2023 Operating EBITDA Margin Expansion

    FY 2023 Operating EBITDA(1) FY 2023 Bridge Key Drivers  Broad-based pricing gains across the portfolio to capture value for ($ in millions) technology, more than offsetting cost and currency $1,258 ($565) ($382)  Volume impacted by Crop Protection destocking and Brazil market, coupled with product

  9. Slide 9: 2024 Guidance

    2024 Guidance(1) Operating Highlights Net Sales EBITDA(2)  LSD Revenue growth driven by Seed $17.4 – 17.7B $3.5 – 3.7B pricing and demand for top technology +6% at mid-point  Benefits from cost deflation, productivity +2% at mid-point Op. EBITDA Margin(2) and royalty reduction Improvement ~90 bps

  10. Slide 10: FY 2024 Operating EBITDA Margin Expansion in Seed and Crop Protection

    FY 2024 Operating EBITDA(1) FY 2024 Bridge Key Drivers  LSD pricing gains in Seed to capture value for technology, offset by ($ in millions) elevated pricing pressure in Crop Protection  Volume gains in both Seed and Crop Protection, offset by CP $3,500 - $3,700 destocking in Latin America and EME

  11. Slide 11: Operating EBITDA 2021 – 2025

    Operating EBITDA 2021 – 2025 Operating EBITDA($B)(1) 2024 / 2025 Key Drivers  Seed growth driven by expected LSD pricing $3.9-$4.4 $3.5 - $3.7  Crop Protection industry expected to rebalance $3.2 $3.4  Continued growth in Biologicals business $2.6  $100M per year royalty improvement 2024 + 2025

  12. Slide 12: Key Sensitivities – 2025 Base Case

    Key Sensitivities – 2025 Base Case 2025 Operating EBITDA(1) Range Downside Case ~$4.2B(2) Upside Case  Greater price pressures  Seed growth with LSD pricing  Increased price performance  Lower Crop Protection growth  Modest Crop Protection growth  Stronger Crop Protection growth  Softer deman

  13. Slide 13: Key Takeaways

    Key Takeaways FY2023 Performance in line with Expectations, EBITDA Margin(1) +116bps Cost, Productivity Actions, and Improved Royalty Expense Adding Value FY2024 / 2025 Outlook Reflects Incremental Earnings and Margin Significant Financial Strength and Confidence in Outlook Focus on Controllables Dr

  14. Slide 14: Appendix

    Appendix 14

  15. Slide 15: 4Q 2023 Highlights

    4Q 2023 Highlights ($ in millions, except EPS) 4Q 2022 4Q 2023 Change Net Sales $3,825 $3,707 (3)% GAAP Income (Loss) from Continuing Operations After Income Taxes $(41) $(231) (463)% Operating EBITDA(1) $370 $386 +4% Operating EBITDA Margin(1) 9.7% 10.4% +74 bps GAAP EPS from Continuing Operations

  16. Slide 16: 4Q 2023 Seed Performance Highlights

    4Q 2023 Seed Performance Highlights ($ in millions) 4Q 2023 vPY 4Q 2023 Revenue by Product Line Net Sales $1,635 (1)% Organic(1) Sales Growth (3)% Other oilseeds(3) Other(4) Operating EBITDA $145 +104% 6% reported growth Operating EBITDA Margin 8.9% +456 bps 10% organic(1) growth Seed Operating EBIT

  17. Slide 17: 4Q 2023 Regional Net Sales Highlights – Seed

    4Q 2023 Regional Net Sales Highlights – Seed North Latin Global Net Sales Reported Organic(1) Reported Organic(1) America(2) 6% 6% America 7% 12% 4Q 2022 4Q 2023 4Q 2022 4Q 2023 Net Sales ($M) $541 $576 Net Sales ($M) $846 $790 Volume Price Currency Portfolio Volume Price Currency Portfolio $1.65B $

  18. Slide 18: 2023 Seed Performance Highlights

    2023 Seed Performance Highlights ($ in millions) FY 2023 vPY FY 2023 Revenue by Product Line Net Sales $9,472 +5% Organic(1) Sales Growth +7% Other(4) Operating EBITDA $2,117 +28% Other oilseeds(3) Operating EBITDA Margin 22.4% +391 bps (1)% reported growth 2% organic(1) growth Corn 8% reported grow

  19. Slide 19: 2023 Regional Net Sales Highlights – Seed

    2023 Regional Net Sales Highlights – Seed North Latin Global Net Sales Reported Organic(1) Reported Organic(1) America(2) 11% 12% America 7% 11% FY 2022 FY 2023 FY 2022 FY 2023 $9.47B Net Sales ($M) $5,178 $5,768 Net Sales ($M) $1,758 $1,637 $8.98B Volume Price Currency Portfolio Volume Price Curren

  20. Slide 20: 4Q 2023 Crop Protection Highlights

    4Q 2023 Crop Protection Highlights ($ in millions) 4Q 2023 vPY 4Q 2023 Revenue by Product Line Net Sales $2,072 (5)% Organic(1) Sales Growth (12)% Other(3) Operating EBITDA $267 (20)% Fungicides Operating EBITDA Margin 12.9% (235) bps (1)% reported growth (4)% organic(1) growth Herbicides (11)% repo

  21. Slide 21: 4Q 2023 Regional Net Sales Highlights – Crop Protection

    4Q 2023 Regional Net Sales Highlights – Crop Protection North Reported Organic(1) Latin Reported Organic(1) Global Net Sales 1% 2% 12% 30% America(2) America 4Q 2022 4Q 2023 4Q 2022 4Q 2023 Net Sales ($M) $931 $921 Net Sales ($M) $835 $732 $2.18B Volume Price Currency Portfolio Volume Price Currency

  22. Slide 22: 2023 Crop Protection Highlights

    2023 Crop Protection Highlights ($ in millions) FY 2023 vPY 2023 Revenue by Product Line Net Sales $7,754 (9)% Organic(1) Sales Growth (12)% Other(3) Operating EBITDA $1,374 (18)% Operating EBITDA Margin 17.7% (215) bps Fungicides (23)% reported growth Crop Protection Operating EBITDA ($ in millions

  23. Slide 23: 2023 Regional Net Sales Highlights – Crop Protection

    2023 Regional Net Sales Highlights – Crop Protection North Latin Global Net Sales Reported Organic(1) Reported Organic(1) America(2) 9% 10% America 16% 30% FY 2022 FY 2023 FY 2022 FY 2023 $8.48B Net Sales ($M) $3,116 $2,822 Net Sales ($M) $2,687 $2,269 Volume Price Currency Portfolio Volume Price Cu

  24. Slide 24: FY 2023 Operating EPS Variance

    FY 2023 Operating EPS(1) Variance Operating EPS(1) ($) $0.74 $(0.44) $2.67 $0.01 $(0.30) $2.69 $(0.14) $0.15 1 2 3 4 5 6 FY 2022 Volume/ Costs Change in Base Currency EGL Portfolio / FY 2023 Price Tax Rate(1) Other Volume/Price 1 Costs 2 Change in Base Income Tax Rate(1) 3  Strong price execution p

  25. Slide 25: FY 2024 Modeling Guidance – Operating Earnings Per Share

    FY 2024 Modeling Guidance – Operating Earnings Per Share(1) ($ in millions, except where noted) Guidance Depreciation and Post-Merge Amortization (625 - 635) Net Interest (Expense) Income (90 – 100) Base Income Tax Rate(1) 21% - 23% Exchange Losses – net, after tax (270 – 290) Net Income – Non-contr

  26. Slide 26: Non-GAAP Calculation of Corteva Operating EBITDA

    Corteva Non-GAAP Calculation of Corteva Operating EBITDA Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 In millions As Reported Margin % As Reported Margin % As Reported Margin % As Reported Margin % Income (loss) from continuing operations, net of tax (GAAP) $

  27. Slide 27: Corteva Segment Information: Net sales by segment

    Corteva Segment Information Net sales by segment Thre e Months Ende d De ce mbe r 31, Twe lve Months Ende d De ce mbe r 31, In millions 2023 2022 2023 2022 Seed $ 1,635 $ 1,646 $ 9,472 $ 8,979 Crop Protection 2,072 2,179 7,754 8,476 Total ne t s ale s $ 3,707 $ 3,825 $ 17,226 $ 17,455 Net Margin (GA

  28. Slide 28: Corteva Significant Items (Pretax)

    Corteva significant items (Pretax) Three Months Ended December 31, Twelve Months Ended December 31, In millions 2023 2022 2023 2022 Seed Restructuring and asset-related charges - net $ (12) $ (31) $ (86) $ (228) Inventory write-offs - - (7) (33) Loss on sale of equity investments - - - (5) Settlemen

  29. Slide 29: Price, Volume Currency Analysis – Region (Q4)

    Corteva Segment Information - Price, Volume Currency Analysis Region Q4 2023 vs. Q4 2022 Percent Change Due To: 2 Net Sales Change (GAAP) Organic Change (Non-GAAP) $ (millions) % $ (millions) % Price & Product Mix Volume Currency Portfolio / Other 1 North America $ 25 2% $ 15 1% (3)% 4% -% 1% EMEA1,

  30. Slide 30: Price, Volume Currency Analysis – Product Line (Q4)

    Corteva Segment Information - Price, Volume Currency Analysis Seed Product Line Q4 2023 vs. Q4 2022 Percent Change Due To: Net Sales Change (GAAP) Organic Change (Non-GAAP)2 $ (millions) % $ (millions) % Price & Product Mix Volume Currency Portfolio / Other 3 Corn $ (26) (2)% $ (56) (4)% 8% (12)% 3%

  31. Slide 31: Price, Volume Currency Analysis – Region (FY)

    Corteva Segment Information - Price, Volume Currency Analysis Region Twelves Months Ended December 31, 2023 vs. Twelve Months Ended December 31, 2022 Percent Change Due To: Net Sales Change (GAAP) Organic Change (Non-GAAP)2 $ (millions) % $ (millions) % Price & Product Mix Volume Currency Portfolio

  32. Slide 32: Price, Volume Currency Analysis – Product Line (FY)

    Corteva Segment Information - Price, Volume Currency Analysis Seed Product Line Twelves Months Ended December 31, 2023 vs. Twelve Months Ended December 31, 2022 Percent Change Due To: 2 Net Sales Change (GAAP) Organic Change (Non-GAAP) $ (millions) % $ (millions) % Price & Product Mix Volume Currenc

  33. Slide 33: Non-GAAP Calculation of Corteva Operating EPS

    Corteva Non-GAAP Calculation of Corteva Operating EPS Three Months Ended December 31, 2023 2022 2023 2022 $ (millions) $ (millions) EPS (diluted) EPS (diluted) Income (loss) from continuing operations attributable to Corteva (GAAP) $ (233) $ (43) (0.33) $ (0.06) 1 Less: Non-operating benefits (costs

  34. Slide 34: Non-GAAP Calculation of Corteva Base Tax Rate

    Corteva Non-GAAP Calculation of Corteva Base Tax Rate Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 Income (loss) from continuing operations before income taxes (GAAP) $ (323) $ (203) $ 1,093 $ 1,426 Add: Significant items (benefit) charge 308 123 579 502 Non-o

  35. Slide 35: Non-GAAP Calculation of Free Cash Flow

    Corteva Non-GAAP Calculation of Free Cash Flow Twelve Months Ended December 31, In millions 2023 2022 Cash provided by (used for) operating activities - continuing operations (GAAP) $ 1,809 $ 912 Less: Capital expenditures (595) (605) Free Cash Flow (Non-GAAP) 1 $ 1,214 $ 307 Twelve Months Ended Dec

  36. Slide 36: Product Disclosures

    Product Disclosures TM ® SM Trademarks and service marks of Corteva Agriscience and its affiliated companies. © 2024 Corteva and its affiliated companies. The transgenic soybean event in Enlist E3® soybeans is jointly developed and owned by Corteva Agriscience LLC and M.S. Technologies, L.L.C. Enlis

Corteva — Q4 2023 Earnings Presentation on 6ix